Allergic Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
The symptoms of Allergic Conjunctivitis include intense itching, puffy eyelids, widened (dilated) vessels in the clear tissue covering the white of the eye, and stringy eye discharge. Its treatment includes antihistamine or anti-inflammatory medications.
The Allergic Conjunctivitis pipeline market research report provides comprehensive information on the therapeutics under development for Allergic Conjunctivitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Allergic Conjunctivitis and features dormant and discontinued projects.
Allergic Conjunctivitis Pipeline Products Market Segmentation by Targets
The key targets in the Allergic Conjunctivitis pipeline products market are Histamine H1 Receptor, Tyrosine Protein Kinase SYK, C-C Chemokine Receptor Type 4, Calcineurin, Calcium Release Activated Calcium Channel Protein 1, Cells Expressing Sialic Acid Binding Ig Like Lectin 8, Chemerin Receptor, Cysteinyl Leukotriene Receptor 1, Cystic Fibrosis Transmembrane Conductance Regulator, Eotaxin, and others.
Allergic Conjunctivitis Pipeline Products Market Analysis by Targets
For more target insights into the Allergic Conjunctivitis pipeline products market, download a free report sample
Allergic Conjunctivitis Pipeline Products Market Segmentation by Mechanisms of Action
The key mechanisms of action in the Allergic Conjunctivitis pipeline products market are Tyrosine Protein Kinase SYK Inhibitor, Histamine H1 Receptor Antagonist, C-C Chemokine Receptor Type 4 Antagonist, Calcineurin Inhibitor, Calcium Release Activated Calcium Channel Protein 1 Blocker, Chemerin Receptor Agonist, Cysteinyl Leukotriene Receptor 1 Antagonist, Cystic Fibrosis Transmembrane Conductance Regulator Activator, Cytotoxic To Cells Expressing Sialic Acid Binding Ig Like Lectin 8, Eotaxin Inhibitor, and others.
Allergic Conjunctivitis Pipeline Products Market Analysis by Mechanisms of Action
For more mechanisms of action insights into the Allergic Conjunctivitis pipeline products market, download a free report sample
Allergic Conjunctivitis Pipeline Products Market Segmentation by Routes of Administration
The key routes of administration in the Allergic Conjunctivitis pipeline products market are ophthalmic, oral, topical, intravenous, nasal, parenteral, rectal, subcutaneous, and sublingual.
Allergic Conjunctivitis Pipeline Products Market Analysis by Routes of Administration
For more routes of administration insights into the Allergic Conjunctivitis pipeline products market, download a free report sample
Allergic Conjunctivitis Pipeline Products Market Segmentation by Molecule Types
The key molecule types in the Allergic Conjunctivitis pipeline products market are small molecule, antisense RNAi oligonucleotide, monoclonal antibody, allergenics (allergen), biologic, fusion protein, gene therapy, peptide, and synthetic peptide.
Allergic Conjunctivitis Pipeline Products Market Analysis by Molecule Types
For more molecule type insights into the Allergic Conjunctivitis pipeline products market, download a free report sample
Competitive Landscape
Some of the leading companies in the Allergic Conjunctivitis pipeline products market are IACTA Pharmaceuticals Inc, Accolade Pharmaceuticals LLC, Aldeyra Therapeutics Inc, Alexion Pharmaceuticals Inc, ALK-Abello AS, Allakos Inc, Boehringer Ingelheim International GmbH, Clevexel Pharma SA, Faes Farma SA, and Intas Pharmaceuticals Ltd.
Allergic Conjunctivitis Pipeline Products Market Analysis by Companies
To know more about the leading companies in the Allergic Conjunctivitis pipeline products market, download a free report sample
Allergic Conjunctivitis Pipeline Products Market Report Overview
| Key Targets | Histamine H1 Receptor, Tyrosine Protein Kinase SYK, C-C Chemokine Receptor Type 4, Calcineurin, Calcium Release Activated Calcium Channel Protein 1, Cells Expressing Sialic Acid Binding Ig Like Lectin 8, Chemerin Receptor, Cysteinyl Leukotriene Receptor 1, Cystic Fibrosis Transmembrane Conductance Regulator, Eotaxin, and Others |
| Key Mechanisms of Action | Tyrosine Protein Kinase SYK Inhibitor, Histamine H1 Receptor Antagonist, C-C Chemokine Receptor Type 4 Antagonist, Calcineurin Inhibitor, Calcium Release Activated Calcium Channel Protein 1 Blocker, Chemerin Receptor Agonist, Cysteinyl Leukotriene Receptor 1 Antagonist, Cystic Fibrosis Transmembrane Conductance Regulator Activator, Cytotoxic To Cells Expressing Sialic Acid Binding Ig Like Lectin 8, Eotaxin Inhibitor, and Others |
| Key Routes of Administration | Ophthalmic, Oral, Topical, Intravenous, Nasal, Parenteral, Rectal, Subcutaneous, and Sublingual |
| Key Molecule Type | Small Molecule, Antisense RNAi Oligonucleotide, Monoclonal Antibody, Allergenics (Allergen), Biologic, Fusion Protein, Gene Therapy, Peptide, and Synthetic Peptide |
| Leading Companies | IACTA Pharmaceuticals Inc, Accolade Pharmaceuticals LLC, Aldeyra Therapeutics Inc, Alexion Pharmaceuticals Inc, ALK-Abello AS, Allakos Inc, Boehringer Ingelheim International GmbH, Clevexel Pharma SA, Faes Farma SA, and Intas Pharmaceuticals Ltd |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Allergic Conjunctivitis (Ophthalmology).
- The pipeline guide reviews pipeline therapeutics for Allergic Conjunctivitis (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Allergic Conjunctivitis (Ophthalmology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Allergic Conjunctivitis (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Allergic Conjunctivitis (Ophthalmology)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolios and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Allergic Conjunctivitis (Ophthalmology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Allergic Conjunctivitis (Ophthalmology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
Aldeyra Therapeutics Inc
Alexion Pharmaceuticals Inc
ALK-Abello AS
Allakos Inc
Boehringer Ingelheim International GmbH
Clevexel Pharma SA
Faes Farma SA
IACTA Pharmaceuticals Inc
Intas Pharmaceuticals Ltd
JW Pharmaceutical Corp
Kissei Pharmaceutical Co Ltd
Nanomerics Ltd
NicOx SA
Ocular Therapeutix Inc
OKYO Pharma Ltd
Oyster Point Pharma Inc
Quark Pharmaceuticals Inc
RAPT Therapeutics Inc
Satellos Bioscience Inc
SIFI SpA
Siolta Therapeutics Inc
Sylentis SAU
Vanda Pharmaceuticals Inc
Wuhan Yicheng Biotechnology Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Allergic Conjunctivitis products market?
The key targets in the Allergic Conjunctivitis pipeline products market are Histamine H1 Receptor, Tyrosine Protein Kinase SYK, C-C Chemokine Receptor Type 4, Calcineurin, Calcium Release Activated Calcium Channel Protein 1, Cells Expressing Sialic Acid Binding Ig Like Lectin 8, Chemerin Receptor, Cysteinyl Leukotriene Receptor 1, Cystic Fibrosis Transmembrane Conductance Regulator, Eotaxin, and others.
-
What are the key mechanisms of action in the Allergic Conjunctivitis pipeline products market?
The key mechanisms of action in the Allergic Conjunctivitis pipeline products market are Tyrosine Protein Kinase SYK Inhibitor, Histamine H1 Receptor Antagonist, C-C Chemokine Receptor Type 4 Antagonist, Calcineurin Inhibitor, Calcium Release Activated Calcium Channel Protein 1 Blocker, Chemerin Receptor Agonist, Cysteinyl Leukotriene Receptor 1 Antagonist, Cystic Fibrosis Transmembrane Conductance Regulator Activator, Cytotoxic To Cells Expressing Sialic Acid Binding Ig Like Lectin 8, Eotaxin Inhibitor, and others.
-
What are the key routes of administration in the Allergic Conjunctivitis pipeline products market?
The key routes of administration in the Allergic Conjunctivitis pipeline products market are ophthalmic, oral, topical, intravenous, nasal, parenteral, rectal, subcutaneous, and sublingual.
-
What are the key molecule types in the Allergic Conjunctivitis pipeline products market?
The key molecule types in the Allergic Conjunctivitis pipeline products market are small molecule, antisense RNAi oligonucleotide, monoclonal antibody, allergenics (allergen), biologic, fusion protein, gene therapy, peptide, and synthetic peptide.
-
Which are the leading companies in the Allergic Conjunctivitis pipeline products market?
Some of the leading companies in the Allergic Conjunctivitis pipeline products market are IACTA Pharmaceuticals Inc, Accolade Pharmaceuticals LLC, Aldeyra Therapeutics Inc, Alexion Pharmaceuticals Inc, ALK-Abello AS, Allakos Inc, Boehringer Ingelheim International GmbH, Clevexel Pharma SA, Faes Farma SA, and Intas Pharmaceuticals Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Sample Report
Allergic Conjunctivitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:
- Assess the relevance of the report
- Evaluate the quality of the report
- Justify the cost
Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.
Related reports
View more Ophthalmology reports